Prostate cancer as a paradigm of multidisciplinary approach? Highlights from the Italian young radiation oncologist meeting
Platinum doublets as first-line treatment for elderly patients with advanced non-small cell lung cancer
Timing of failure in limited disease (stage I-III) small-cell lung cancer patients treated with chemoradiotherapy: a retrospective analysis
Non-small cell lung cancer in surgically treated women
What is the price of functional surgical organ preservation in local-regionally advanced supraglottic cancer? Long-term outcome for partial laryngectomy followed by radiotherapy in 32 patients
Optimal local control and tolerability of three-dimensional conformal radiation therapy in prostate cancer: a single institutional experience of dose escalation in 125 patients
The evaluation of bcl -2 expression as a prognostic marker in early stage laryngeal cancer
Increased expression of EphA2 and E-N cadherin switch in primary hepatocellular carcinoma
Frequent losses of heterozygosity in the mitofusin 2 gene in hepatocellular carcinoma: their relationship to clinicopathological features
Trefoil factor 1 gene alternations and expression in colorectal carcinomas
Temperament and character and quality of life in lung cancer patients
Insulin-like growth factor I regulates the expression of isoforms of Wilms' tumor 1 gene in breast cancer
Tumor refractoriness to endostatin anti-angiogenesis is associated with the recruitment of CD11b+Gr1+ myeloid cells and inflammatory cytokines
18FDG-PET for early prediction of complete response to lapatinib and capecitabine in HER2-positive metastatic breast cancer: a case report
Lapatinib in second-line treatment for metastatic breast cancer: rapid clinical benefit and long-term response
Lapatinib and letrozole as first-line therapy for metastatic breast cancer: case report of bone metastasis 18 years later
Metastatic breast cancer treated with lapatinib with a prolonged benefit: a case report and a review of therapeutic options available
Over 17-month complete clinical brain response with a well-tolerated lapatinib plus capecitabine combination in a very young patient afflicted by HER2-positive metastatic breast cancer
Rapid tumor shrinkage with lapatinib plus capecitabine in a patient with massive liver involvement
Case report: long-lasting response in a patient with metastatic renal cell cancer receiving antitumor cytotoxic T lymphocytes
Sunitinib therapy in metastatic papillary thyroid cancer
Cardiovascular adverse events complicating the administration of rituximab: report of two cases
Accreditation for excellence of cancer research institutes: recommendations from the Italian Network of Comprehensive Cancer Centers
The electronic cigarette: potential health benefit or mere business?
Ipilimumab in the treatment of metastatic melanoma: a summary of recent studies